Print PDF
Axinn Represents Alvogen Before FTC in Connection with Divested Products from Pfizer and Hospira
August 25, 2015

Axinn represented Alvogen before the Federal Trade Commission in connection with Alvogen’s acquisition of four divested products from Pfizer and Hospira. The Axinn team was led by Michael Keeley and Kenina Lee.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.